Several viral infectious diseases appear limitless since the beginning of the 21st century,
expanding into pandemic lengths. Thus, there are extensive efforts to provide more efficient …

Cell therapy approaches that employ engineered mammalian cells for on-demand
production of therapeutic agents in the patient's body are moving beyond proof-of-concept in …

Arming human cells with synthetic gene circuits enables to expand their capacity to execute
superior sensing and response actions, offering tremendous potential for innovative cellular …

Cell-cell interactions govern differentiation and cell competition in pluripotent cells during
early development, but the investigation of such processes is hindered by a lack of efficient …

Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue
damage, and blood clotting. Engineered biomaterials from the nano-to the macroscale can …

Due to the vastness of the science virology, it is no longer an offshoot solely of the
microbiology. Viruses have become as the causative agents of major epidemics throughout …

Synthetic and chimeric receptors capable of recognizing and responding to user-defined
antigens have enabled “smart” therapeutics based on engineered cells. These cell …

Type-I interferons (IFN-I) are the innate immune system's principal defense against viral
infections. Human immunodeficiency virus-1 (HIV-1) has evolved several ways to suppress …

The COVID-19 pandemic has demonstrated the need for exploring different diagnostic and
therapeutic modalities to tackle future viral threats. In this vein, we propose the idea of …

Antibodies against hepatitis B virus S protein can protect against hepatitis B virus (HBV)
infection. Therefore, hepatitis B immunoglobulin (HBIG), which contains HBsAb, is used …